A detailed history of Marble Harbor Investment Counsel, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Marble Harbor Investment Counsel, LLC holds 3,843 shares of BDX stock, worth $948,836. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,843
Previous 3,843 -0.0%
Holding current value
$948,836
Previous $898,000 3.12%
% of portfolio
0.11%
Previous 0.11%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$225.07 - $246.17 $33,535 - $36,679
-149 Reduced 3.73%
3,843 $898,000
Q1 2024

May 09, 2024

SELL
$233.45 - $247.73 $157,812 - $167,465
-676 Reduced 14.48%
3,992 $987,000
Q1 2023

May 10, 2023

SELL
$229.71 - $259.35 $29,173 - $32,937
-127 Reduced 2.65%
4,668 $1.16 Million
Q3 2022

Nov 08, 2022

SELL
$51.03 - $264.23 $1,888 - $9,776
-37 Reduced 0.77%
4,795 $1.07 Million
Q2 2022

Aug 11, 2022

BUY
$234.74 - $275.42 $18,074 - $21,207
77 Added 1.62%
4,832 $1.19 Million
Q1 2022

May 09, 2022

BUY
$243.64 - $270.48 $633,464 - $703,248
2,600 Added 120.65%
4,755 $1.27 Million
Q4 2021

Feb 10, 2022

BUY
$230.08 - $250.94 $250,557 - $273,273
1,089 Added 102.16%
2,155 $542,000
Q3 2021

Nov 10, 2021

SELL
$232.72 - $256.47 $253,432 - $279,295
-1,089 Reduced 50.53%
1,066 $262,000
Q2 2021

Aug 09, 2021

SELL
$232.65 - $254.58 $81,427 - $89,103
-350 Reduced 13.97%
2,155 $524,000
Q3 2019

Nov 06, 2019

SELL
$230.58 - $256.08 $32,742 - $36,363
-142 Reduced 5.36%
2,505 $634,000
Q1 2018

May 10, 2018

BUY
$205.46 - $240.27 $171,559 - $200,625
835 Added 46.08%
2,647 $574,000
Q3 2017

Nov 07, 2017

BUY
$186.89 - $198.9 $338,644 - $360,406
1,812
1,812 $355,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $70.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Marble Harbor Investment Counsel, LLC Portfolio

Follow Marble Harbor Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marble Harbor Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marble Harbor Investment Counsel, LLC with notifications on news.